Streetbeat News

Stock Prices

FBRX

Forte Biosciences (NASDAQ:FBRX) reported a Q2 EPS loss of $(0.27), missing the analyst consensus estimate of $(0.17) by 58.82%. This represents a 35.71% improvement over the $(0.42) loss per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:17 pm

PYCR

Paycor HCM (NASDAQ:PYCR) reported Q4 2024 adjusted EPS of $0.11, beating the $0.09 estimate. Sales were $164.8M, surpassing the $161.172M estimate and marking a 17.68% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:17 pm

AISP

Airship AI Holdings (NASDAQ:AISP) reported a significant improvement in its Q2 earnings, with EPS rising to $0.58 from a loss of $(0.14) YoY, and sales increasing to $5.36M from $1.81M YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:17 pm

SRFM

Surf Air Mobility Inc. (NYSE:SRFM) reported Q2 2024 GAAP EPS of $(0.33), missing the $(0.32) estimate, but achieved sales of $32.37M, beating the $29.42M estimate. EPS improved significantly from $(3.14) last year, and sales surged by 422.45% from $6.20M.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:16 pm

RAMP

LiveRamp has increased its share repurchase program by $200 million, bringing the total to $1.3 billion, and extended the expiration date by two years to December 31, 2026.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:16 pm

NVGS

Navigator Holdings (NYSE:NVGS) reported Q2 earnings per share of $0.34, beating the analyst estimate of $0.33. Sales were $146.68 million, surpassing the $133.49 million estimate. This represents a 36% increase in EPS and an 8.38% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:15 pm

MOVE

Movano (NASDAQ:MOVE) reported a Q2 GAAP EPS of $(0.06), showing a significant improvement from $(0.17) per share in the same period last year, representing a 64.71% increase.

Portfolio Pulse from saritha@benzinga.com

August 14, 2024 | 8:15 pm

PSTV

Plus Therapeutics (NASDAQ:PSTV) reported Q2 sales of $1.28 million, missing the analyst consensus estimate of $1.68 million by 23.64%. This represents a 31.01% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:15 pm

IFIN

INFINT Acquisition Corp. has announced its decision to delist from the New York Stock Exchange (NYSE).

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:15 pm

XOM

Recent options trading trends for Exxon Mobil (NYSE:XOM) show a predominantly bearish sentiment among large investors, with 55% of trades being bearish and 37% bullish. The total value of put options is $585,261, while call options amount to $959,525. The price window targeted by these trades ranges from $50.0 to $130.0. Current trading volume for XOM is 9,197,916, with the stock price up by 0.88% to $118.9. The next earnings report is due in 72 days.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 8:15 pm